Clinical Trials Browser

Phase 2/3 × Unknown × IFL protocol × Clear all

NCT02942706 2021-04-30

Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC

Phase 2/3 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT02978313 2016-11-30

Cetuximab Monotherapy Maintenance Treatment in mCRC

Phase 2/3 Unknown

Gastrointestinal

Colorectal Neoplasms